Anaphylaxis to vaccines is historically a rare event. The coronavirus disease 2019 pandemic
drove the need for rapid vaccine production applying a novel antigen delivery system …

The US Food and Drug Administration (FDA) has recently issued an Emergency Use
Authorization (EUA) for 2 highly effective coronavirus disease 2019 (COVID-19) vaccines …

Importance As of May 2021, more than 32 million cases of COVID-19 have been confirmed
in the United States, resulting in more than 615 000 deaths. Anaphylactic reactions …

Background For the preventive treatment of the 2019 coronavirus disease (COVID-19) an
unprecedented global research effort studied the safety and efficacy of new vaccine …

Background Currently there is no systematic review and meta-analysis of the global
incidence rates of anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines in …

Although allergic responses to the mRNA COVID-19 vaccines are rare, recent reports have
suggested that a small number of individuals with allergy to polyethylene glycol (PEG), a …

It has been 3 years since the coronavirus disease 2019 (COVID-19) pandemic was initially
declared, and 2 years have passed since the first COVID-19 vaccines were introduced …

Background The Centers for Disease Control and Prevention state that a severe or
immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a …

Recent approval of two novel mRNA SARS-CoV-2/COVID-19 vaccines by various regulatory
agencies has provided hope that we may finally be able to end the pandemic that has …

Conventional vaccines have been widely studied, along with their risk of causing allergic
reactions. These generally consist of mild local reactions and only rarely severe …